Brief: BioInvent Gets Milestone Payment From Bayer/Hope Medicine Licensing Agreement

BioInvent International AB

28/04/2022 07:38

April 28 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT RECEIVES MILESTONE PAYMENT FROM BAYER/HOPE
MEDICINE
LICENSING AGREEMENT
    * RECEIVES EUR 500,000 FOLLOWING ENROLLMENT OF FIRST PATIENT
IN A
PHASE 2 TRIAL OF HMI-115 FOR TREATMENT OF ENDOMETRIOSIS IN
PRE-MENOPAUSAL WOMEN

Source text for Eikon:  ID:nMFN3X0jq6 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))